Equities

Multiplan Corp

MPLN:NYQ

Multiplan Corp

Actions
Health CareHealth Care Providers
  • Price (USD)7.02
  • Today's Change0.57 / 8.84%
  • Shares traded83.48k
  • 1 Year change-85.96%
  • Beta0.5913
Data delayed at least 15 minutes, as of Nov 21 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments72334185
Total Receivables, Net7779100
Total Inventory------
Prepaid expenses252430
Other current assets, total21104.05
Total current assets194447319
Property, plant & equipment, net287257243
Goodwill, net3,8293,7054,363
Intangibles, net2,6332,9403,285
Long term investments------
Note receivable - long term------
Other long term assets22229.70
Total assets6,9657,3718,220
LIABILITIES
Accounts payable201313
Accrued expenses134149116
Notes payable/short-term debt000
Current portion long-term debt/capital leases131313
Other current liabilities, total----0
Total current liabilities167176142
Total long term debt4,5334,7424,879
Total debt4,5464,7554,892
Deferred income tax522639754
Minority interest------
Other liabilities, total3423101
Total liabilities5,2565,5815,876
SHAREHOLDERS EQUITY
Common stock0.070.070.07
Additional paid-in capital2,3492,3302,312
Retained earnings (accumulated deficit)(499)(348)225
Treasury stock - common(128)(192)(192)
Unrealized gain (loss)------
Other equity, total(12)----
Total equity1,7091,7912,345
Total liabilities & shareholders' equity6,9657,3718,220
Total common shares outstanding161616
Treasury shares - common primary issue0.490.680.68
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.